Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

被引：50

作者：

Saisho, Yoshifumi ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan

来源：

JOURNAL OF CLINICAL MEDICINE | 2014年 / 3卷 / 03期

关键词：

type; 2; diabetes; beta cell; insulin secretion; therapy;

D O I：

10.3390/jcm3030923

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Type 2 diabetes (T2DM) is characterized by insulin resistance and beta cell dysfunction. Recent evidence has emerged that beta cell dysfunction is a common pathogenetic feature of both type 1 and type 2 diabetes, and T2DM never develops without beta cell dysfunction. Therefore, treatment of T2DM should aim to restore beta cell function. Although the treatment of T2DM has greatly improved over the past few decades, remaining issues in the current treatment of T2DM include (1) hypoglycemia; (2) body weight gain; (3) peripheral hyperinsulinemia and (4) postprandial hyperglycemia, which are all associated with inappropriate insulin supplementation, again underpinning the important role of endogenous and physiological insulin secretion in the management of T2DM. This review summarizes the current knowledge on beta cell function in T2DM and discusses the treatment strategy for T2DM in relation to beta cell dysfunction.

引用

页码：923 / 943

页数：21

共 126 条

[91] Post Hoc Subgroup Analysis of the HEART2D Trial Demonstrates Lower Cardiovascular Risk in Older Patients Targeting Postprandial Versus Fasting/Premeal Glycemia [J].

Raz, Itamar ;

Ceriello, Antonio ;

Wilson, Peter W. ;

Battioui, Chakib ;

Su, Eric W. ;

Kerr, Lisa ;

Jones, Cate A. ;

Milicevic, Zvonko ;

Jacober, Scott J. .

DIABETES CARE, 2011, 34 (07) :1511-1513

[92] Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial [J].

Raz, Itamar ;

Wilson, Peter W. F. ;

Strojek, Krzysztof ;

Kowalska, Irina ;

Bozikov, Velimir ;

Gitt, Anselm K. ;

Jermendy, Gyoergy ;

Campaigne, Barbara N. ;

Kerr, Lisa ;

Milicevic, Zvonko ;

Jacober, Scott J. .

DIABETES CARE, 2009, 32 (03) :381-386

[93] Endothelial insulin receptor expression in human atherosclerotic plaques: Linking micro- and macrovascular disease in diabetes? [J].

Rensing, K. L. ;

von der Thuesen, J. H. ;

Weijers, E. M. ;

Bloemendaal, F. M. Houttuijn ;

van Lammeren, G. W. ;

Vink, A. ;

van der Wal, A. C. ;

van Hinsbergh, V. W. M. ;

van der Loos, C. M. ;

Stroes, E. S. ;

Koolwijk, P. ;

Twickler, Th. B. .

ATHEROSCLEROSIS, 2012, 222 (01) :208-215

[94] Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture [J].

Risso, A ;

Mercuri, F ;

Quagliaro, L ;

Damante, G ;

Ceriello, A .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 281 (05) :E924-E930

[95] The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases β-cell mass in diabetic mice [J].

Rolin, B ;

Larsen, MO ;

Gotfredsen, CF ;

Deacon, CF ;

Carr, RD ;

Wilken, M ;

Knudsen, LB .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (04) :E745-E752

[96] Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study [J].

Rosenstock, J. ;

Fonseca, V. ;

McGill, J. B. ;

Riddle, M. ;

Halle, J. P. ;

Hramiak, I. ;

Johnston, P. ;

Davis, M. .

DIABETOLOGIA, 2009, 52 (09) :1971-1973

[97] Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) A 26-week double-blind study [J].

Russell-Jones, David ;

Cuddihy, Robert M. ;

Hanefeld, Markolf ;

Kumar, Ajay ;

Gonzalez, Jose G. ;

Chan, Melanie ;

Wolka, Anne M. ;

Boardman, Marilyn K. .

DIABETES CARE, 2012, 35 (02) :252-258

[98] RETRACTED: Metformin monotherapy for type 2 diabetes mellitus - art. no. CD002966.pub3 (Retracted Article) [J].

Saenz, A ;

Fernandez-Esteban, I ;

Mataix, A ;

Ausejo, M ;

Roque, M ;

Moher, D .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03)

[99]

Saisho Y., 2014, J MOL GENET MED S, Vs1, P008, DOI [10.4172/1747-0862.S1-008, DOI 10.4172/1747-0862.S1-008]

[100] Lower beta cell function relates to sustained higher glycated albumin to glycated hemoglobin ratio in Japanese patients with type 2 diabetes [J].

Saisho, Yoshifumi ;

Tanaka, Kumiko ;

Abe, Takayuki ;

Kawai, Toshihide ;

Itoh, Hiroshi .

ENDOCRINE JOURNAL, 2014, 61 (02) :149-157

← 4 5 6 7 8 9 10 11 12 13 →